(Q34659699)

English

The prophylactic use of lamivudine can maintain dose-intensity of adriamycin in hepatitis-B surface antigen (HBs Ag)-positive patients with Non-Hodgkin's lymphoma who receive cytotoxic chemotherapy

scientific article

Statements

The prophylactic use of lamivudine can maintain dose-intensity of adriamycin in hepatitis-B surface antigen (HBs Ag)-positive patients with Non-Hodgkin's lymphoma who receive cytotoxic chemotherapy (English)
Gyeong-Won Lee
Min-Hee Ryu
Jae-Lyun Lee
Sukjoong Oh
Eunkyoung Kim
Jae-Hwan Lee
Seung-Bae Kim
Sang-We Kim
Kyoo-Hyung Lee
Woo-Kun Kim
Jung-Shin Lee
Yoon-Koo Kang
1 December 2003

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit